Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.
1989
Impaired osteoblast function in osteoporosis: comparison between calcium balance and dynamic histomorphometry.
1984
Child abuse: Adolescent records vs. adult recall
1990 Standout
Health benefits of physical activity: the evidence
2006 Standout
Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.
1991
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Screening for ovarian cancer: a pilot randomised controlled trial
1999
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Detection of endometrial cancer in postmenopausal women by transvaginal ultrasonography and colour flow imaging.
1990
Ovarian cancer
2014 Standout
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer
1990
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
1995 Standout
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Endometriosis
2009 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Ultrasound screening for familial ovarian cancer
1991
The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk
1988
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
2002 Standout
Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints
1988
Skeletal effects of estrogens
1999
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy
1993
Osteoporosis: now and the future
2011 Standout
Prediction of bone density from vitamin D receptor alleles
1994 StandoutNature
Optimising delivery systems for HRT
1999
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
The risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacement
1992
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Symptom relief and side effects of postmenopausal hormones: results from the postmenopausal estrogen/progestin interventions trial
1998
Estrogen-Progestin Replacement Therapy and Endometrial Cancer
1997
Neuroanatomical Localization, Pharmacological Characterization and Functions of CGRP, Related Peptides and Their Receptors
1997
A review of postgastrectomy bone disease
1992
Polymorphisms in the Sclerosteosis/van Buchem Disease Gene (SOST) Region Are Associated with Bone-Mineral Density in Elderly Whites
2004 StandoutNobel
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
CGRP-induced activation of KATP channels in follicular Xenopus oocytes
1994
Postmenopausal Estrogen Therapy and Cardiovascular Disease
1991 Standout
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer
1991
Actual Causes of Death in the United States, 2000
2004 Standout
Ultrasound evaluation of pelvic masses: predictors of malignancy for the general gynecologist
1999
Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women
1997
Calcitonin Gene-Related Peptide (CGRP) and CGRP Receptor Expression at the Human Implantation Site
2002
Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease
1999
Ghrelin: Structure and Function
2005 Standout
Use of proteomic patterns in serum to identify ovarian cancer
2002 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Estrogen replacement therapy and the risk of endometrial cancer: Remaining controversies
1990
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
2000
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
1998 Standout
Cancer of the Ovary
2004 Standout
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
1998 StandoutNature
Epidemiology of Obstructive Sleep Apnea
2002 Standout
The Risk of Endometrial Neoplasia and Treatment with Estrogens and Estrogen ‐ Progestogen Combinations: First results of a cohort study after one to four completed years of observation
1986
Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.
1992 StandoutNobel
Involutional Osteoporosis
1986 Standout
Endometrium and plasma hormone profile in the peri-menopause and post-menopause
1986
Biologic Effects of Transdermal Estradiol
1986
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Breast cancer and hormone-replacement therapy in the Million Women Study
2003 Standout
Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss
1994
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
1987 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Pregnancies following high-dose cyclophosphamide with or without high- dose busulfan or total-body irradiation and bone marrow transplantation
1996
The Effects of Estrogens and Progestogens on the Endometrium
1987
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy
1986
Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density.
1986
Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered
1986
Endometrial hyperplasia in women on cyclic or continuous estrogen regimens
1982
Calcitonin Gene-Related Peptide Decreases Expression of HLA-DR and CD86 by Human Dendritic Cells and Dampens Dendritic Cell-Driven T Cell-Proliferative Responses Via the Type I Calcitonin Gene-Related Peptide Receptor
2000 StandoutNobel
Prevention of endometrial cancer with progestogens
1986
The Comparative Effect on Bone Density, Endometrium, and Lipids of Continuous Hormones as Replacement Therapy (CHART Study)
1996
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Genetic determinants of bone mass in adults. A twin study.
1987
A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart Disease
1985
Distribution of Progesterone Receptor, Estradiol Dehydrogenase, and 20α-Dihydroprogesterone Dehydrogenase Activities in Human Endometrial Glands and Stroma: Progestin Induction of Steroid Dehydrogenase Activities in Vitro Is Restricted to the Glandular Epithelium*
1982
Estrogen and Coronary Heart Disease in Women
1991 Standout
Dual‐photon bone densitometry in normal Australian women: a cross‐sectional study
1987
Estimation of Regression Coefficients When Some Regressors are not Always Observed
1994 Standout
Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
2004
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Risk Factors for Hip Fracture in White Women
1995 Standout
Surgical approach to hysterectomy for benign gynaecological disease
2015 Standout
Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
2014
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Works of MI Whitehead being referenced
Postmenopausal osteoporosis.
1982
Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer.
1989
Paradoxical effects of hormone replacement therapy on breast tenderness in postmenopausal women
1994
Endometrial assessment re‐visited
1999
Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis
1996
Biochemical analyses of separated epithelium and stroma from endometria of premenopausal and postmenopausal women receiving estrogen and progestins
1981
Transvaginal colour flow imaging: A possible new screening technique for ovarian cancer
1990
Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
1994
Increased concentration of circulating calcitonin gene related peptide during normal human pregnancy.
1986
OESTRADIOL: THE PREDOMINANT INTRANUCLEAR OESTROGEN IN THE ENDOMETRIUM OF OESTROGEN‐TREATED POSTMENOPAUSAL WOMEN
1981
A controlled trial of naproxen sodium for relief of pain associated with Vabra suction curettage
1983
Successful pregnancy following bone marrow transplantation for leukaemia.
1990
Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal Endometrium
1981
Effect of estrogen and progestin treatments on endometria from postmenopausal women.
1979
Dose-related changes in vaginal cytology after topical conjugated equine oestrogens.
1982
Oestriol with oestradiol verses oestradiol alone: a comparison of endometrial, symptomatic and psychological effects
1986